- Securities Code: 301111
Securities Abbreviation: Guangdong Wannianqing
Announcement Number: 2026-028
Implementation Announcement of 2025 Annual Equity Distribution
The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Guangdong Wannianqing Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") has approved the 2025 annual equity distribution plan at the shareholders' meeting held on May 19, 2026. The relevant specific matters are announced as follows: